<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33159016</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1945-4589</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>22</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>Aging</Title><ISOAbbreviation>Aging (Albany NY)</ISOAbbreviation></Journal><ArticleTitle>Identification of novel <i>FUS</i> and <i>TARDBP</i> gene mutations in Chinese amyotrophic lateral sclerosis patients with HRM analysis.</ArticleTitle><Pagination><StartPage>22859</StartPage><EndPage>22868</EndPage><MedlinePgn>22859-22868</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/aging.103967</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor neurons. More than 30 genes have been linked to ALS to date, including <i>FUS</i> and <i>TARDBP</i>, which exhibit similar roles in RNA metabolism. This study explored the use of high-resolution melting (HRM) analysis to screen for <i>FUS</i> and <i>TARDBP</i> mutation hotspot regions in 146 Chinese ALS patients, which achieved 100% detection. Two <i>FUS</i> mutations were observed in two different familial ALS probands, a missense mutation (p.R521H) and a novel splicing mutation (c.1541+1G&gt;A). Five <i>TARDBP</i> mutations were identified in six ALS patients, including a novel 3'UTR mutation (c.*731A&gt;G) and four missense mutations (p.G294V, p.M337V, p.G348V, and p.I383V). We found that <i>FUS</i> mutations were present in 1.4% of Chinese ALS patients, whereas <i>TARDBP</i> mutations were responsible for 4.1% of Chinese ALS cases. Here, we describe the accuracy of using highly sensitive HRM analysis to identify two novel <i>FUS</i> and <i>TARDBP</i> mutations in Chinese sporadic and familial ALS cases. Our study contributes to the further understanding of the genetic and phenotypic diversity of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Shengyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Jiafan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hongchen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chunking General Hospital, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Shugui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chunking General Hospital, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kangning</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Army Medical University, Army Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Army Medical University, Army Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xueqing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Aging (Albany NY)</MedlineTA><NlmUniqueID>101508617</NlmUniqueID><ISSNLinking>1945-4589</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">HRM analysis</Keyword><Keyword MajorTopicYN="N">TARDBP</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement><b>CONFLICTS OF INTEREST:</b> The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>7</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33159016</ArticleId><ArticleId IdType="pmc">PMC7746354</ArticleId><ArticleId IdType="doi">10.18632/aging.103967</ArticleId><ArticleId IdType="pii">103967</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. Amyotrophic lateral sclerosis. Lancet. 2011; 377:942&#x2013;55. 10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013; 41:118&#x2013;30. 10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME. The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler. 2009; 10:324&#x2013;31. 10.3109/17482960903009054</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903009054</ArticleId><ArticleId IdType="pubmed">19922119</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014; 17:17&#x2013;23. 10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xfc;ller K, Marroquin N, Nordin F, H&#xfc;bers A, Weydt P, Pinto S, Press R, Millecamps S, et al.. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015; 18:631&#x2013;36. 10.1038/nn.4000</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Vajda A, McLaughlin RL, Heverin M, Thorpe O, Abrahams S, Al-Chalabi A, Hardiman O. Genetic testing in ALS: a survey of current practices. Neurology. 2017; 88:991&#x2013;99. 10.1212/WNL.0000000000003686</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003686</ArticleId><ArticleId IdType="pmc">PMC5333513</ArticleId><ArticleId IdType="pubmed">28159885</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016; 539:197&#x2013;206. 10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y, Huang EJ. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res. 2016; 1647:65&#x2013;78. 10.1016/j.brainres.2016.03.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.03.036</ArticleId><ArticleId IdType="pmc">PMC5003642</ArticleId><ArticleId IdType="pubmed">27033831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Rouleau GA, Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat. 2013; 34:812&#x2013;26. 10.1002/humu.22319</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22319</ArticleId><ArticleId IdType="pubmed">23559573</ArticleId></ArticleIdList></Reference><Reference><Citation>Drepper C, Herrmann T, Wessig C, Beck M, Sendtner M. C-terminal FUS/TLS mutations in familial and sporadic ALS in Germany. Neurobiol Aging. 2011; 32:548.e1&#x2013;4. 10.1016/j.neurobiolaging.2009.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.11.017</ArticleId><ArticleId IdType="pubmed">20018407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Ren X, Bai X, Zhang T, Wang Y, Li K, Li G. Identification of gene mutation in patients with osteogenesis imperfect using high resolution melting analysis. Sci Rep. 2015; 5:13468. 10.1038/srep13468</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13468</ArticleId><ArticleId IdType="pmc">PMC4549685</ArticleId><ArticleId IdType="pubmed">26307460</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery J, Wittwer CT, Palais R, Zhou L. Simultaneous mutation scanning and genotyping by high-resolution DNA melting analysis. Nat Protoc. 2007; 2:59&#x2013;66. 10.1038/nprot.2007.10</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.10</ArticleId><ArticleId IdType="pubmed">17401339</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O, Powell JF, Andersen PM, Al-Chalabi A. ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat. 2012; 33:1345&#x2013;51. 10.1002/humu.22157</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22157</ArticleId><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, et al.. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009; 323:1205&#x2013;08. 10.1126/science.1166066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Bo R, Ghezzi S, Corti S, Pandolfo M, Ranieri M, Santoro D, Ghione I, Prelle A, Orsetti V, Mancuso M, Sorar&#xf9; G, Briani C, Angelini C, et al.. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur J Neurol. 2009; 16:727&#x2013;32. 10.1111/j.1468-1331.2009.02574.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02574.x</ArticleId><ArticleId IdType="pubmed">19236453</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M, Zollino M, Conte A, Del Grande A, Marangi G, Lucchini M, Mirabella M, Romano A, Piacentini R, Bisogni G, Lattante S, Luigetti M, Rossini PM, Moncada A. Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations. Neurobiol Aging. 2015; 36:2005.e5&#x2013;13. 10.1016/j.neurobiolaging.2015.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.009</ArticleId><ArticleId IdType="pubmed">25792239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD, et al.. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008; 319:1668&#x2013;72. 10.1126/science.1154584</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J, Goodall EF, Smith W, Highley JR, Masanzu R, Hartley JA, Hibberd R, Hollinger HC, Wharton SB, Morrison KE, Ince PG, McDermott CJ, Shaw PJ. Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis. Neurogenetics. 2010; 11:217&#x2013;25. 10.1007/s10048-009-0218-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-009-0218-9</ArticleId><ArticleId IdType="pubmed">19760257</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, et al.. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008; 4:e1000193. 10.1371/journal.pgen.1000193</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH Jr. Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015; 125:2548. 10.1172/JCI82693</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI82693</ArticleId><ArticleId IdType="pmc">PMC4518693</ArticleId><ArticleId IdType="pubmed">26030230</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Talbot K, Ansorge O. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathol Commun. 2016; 4:99. 10.1186/s40478-016-0358-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0358-8</ArticleId><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017; 88:540&#x2013;49. 10.1136/jnnp-2016-315018</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, Neumann M, Haass C. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 2010; 29:2841&#x2013;57. 10.1038/emboj.2010.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ Jr, Sapp P, McKenna-Yasek D, Brown RH Jr, Hayward LJ. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet. 2010; 19:4160&#x2013;75. 10.1093/hmg/ddq335</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq335</ArticleId><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolin C, D&#x2019;Ascenzo C, Querin G, Gaiani A, Boaretto F, Salvoro C, Vazza G, Angelini C, Cagnin A, Pegoraro E, Sorar&#xf9; G, Mostacciuolo ML. Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. Neurobiol Aging. 2014; 35:1212.e7&#x2013;10. 10.1016/j.neurobiolaging.2013.10.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.10.093</ArticleId><ArticleId IdType="pubmed">24325798</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, Johnston A, Rutherford N, Wojtas A, Kennelly K, Wszolek ZK, Graff-Radford N, Boylan K, Rademakers R. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum Mutat. 2010; 31:E1377&#x2013;89. 10.1002/humu.21241</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21241</ArticleId><ArticleId IdType="pmc">PMC2922682</ArticleId><ArticleId IdType="pubmed">20232451</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, St-Onge J, Daoud H, Desjarlais A, Bouchard JP, Dupr&#xe9; N, Camu W, Dion PA, Rouleau GA. Identification of a FUS splicing mutation in a large family with amyotrophic lateral sclerosis. J Hum Genet. 2011; 56:247&#x2013;49. 10.1038/jhg.2010.162</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jhg.2010.162</ArticleId><ArticleId IdType="pubmed">21160488</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiihashi G, Ito D, Yagi T, Nihei Y, Ebine T, Suzuki N. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain. 2016; 139:2380&#x2013;94. 10.1093/brain/aww161</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww161</ArticleId><ArticleId IdType="pubmed">27368346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D, Yagi T, Ikawa M, Suzuki N. Characterization of inclusion bodies with cytoprotective properties formed by seipinopathy-linked mutant seipin. Hum Mol Genet. 2012; 21:635&#x2013;46. 10.1093/hmg/ddr497</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr497</ArticleId><ArticleId IdType="pubmed">22045697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L, Jiao B, Xiao T, Zhou L, Zhou Z, Du J, Yan X, Wang J, Tang B, Shen L. Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China. Sci Rep. 2016; 6:32478. 10.1038/srep32478</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep32478</ArticleId><ArticleId IdType="pmc">PMC5015023</ArticleId><ArticleId IdType="pubmed">27604643</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Durnall JC, Thoeng AD, Warraich ST, Nicholson GA, Blair IP. A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred. J Neurol Neurosurg Psychiatry. 2009; 80:1286&#x2013;88. 10.1136/jnnp.2008.163261</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.163261</ArticleId><ArticleId IdType="pubmed">19864664</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JA, Min J, Staropoli JF, Collin E, Bi S, Feng X, Barone R, Cao Y, O&#x2019;Malley L, Xin W, Mullen TE, Sims KB. SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experience. Amyotroph Lateral Scler. 2012; 13:217&#x2013;22. 10.3109/17482968.2011.643899</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.643899</ArticleId><ArticleId IdType="pubmed">22292843</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M, Romano V, Avenda&#xf1;o-V&#xe1;zquez SE, Bembich S, Buratti E, Baralle FE. Role of selected mutations in the Q/N rich region of TDP-43 in EGFP-12xQ/n-induced aggregate formation. Brain Res. 2012; 1462:139&#x2013;50. 10.1016/j.brainres.2012.02.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.031</ArticleId><ArticleId IdType="pubmed">22406069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Peng Y, Wang XN, Liu MS, Li XG, Cui LY. Screening of the TARDBP gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin. Neurobiol Aging. 2012; 33:2229.e11&#x2013;18. 10.1016/j.neurobiolaging.2012.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.03.014</ArticleId><ArticleId IdType="pubmed">22575358</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Rademakers R, Petrucelli L. TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43. J Alzheimers Dis. 2013. (Suppl 1); 33:S35&#x2013;45. 10.3233/JAD-2012-129036</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-129036</ArticleId><ArticleId IdType="pmc">PMC3532959</ArticleId><ArticleId IdType="pubmed">22751173</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng YW, Lee MJ, Chen TF, Cheng TW, Lai YM, Hua MS, Chiu MJ. A single nucleotide TDP-43 mutation within a Taiwanese family: a multifaceted demon. Amyotroph Lateral Scler Frontotemporal Degener. 2016; 17:292&#x2013;94. 10.3109/21678421.2015.1111905</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1111905</ArticleId><ArticleId IdType="pubmed">26581115</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zo&#x11f;uz A, Uyan &#xd6;, Birdal G, Iskender C, Kartal E, Lahut S, &#xd6;m&#xfc;r &#xd6;, Agim ZS, Eken AG, Sen NE, Kavak P, Sayg&#x131; C, Sapp PC, et al.. The distinct genetic pattern of ALS in Turkey and novel mutations. Neurobiol Aging. 2015; 36:1764.e9&#x2013;18. 10.1016/j.neurobiolaging.2014.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.12.032</ArticleId><ArticleId IdType="pmc">PMC6591733</ArticleId><ArticleId IdType="pubmed">25681989</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama A, Sugai A, Kato T, Ishihara T, Shiga A, Toyoshima Y, Koyama M, Konno T, Hirokawa S, Yokoseki A, Nishizawa M, Kakita A, Takahashi H, Onodera O. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43. Nucleic Acids Res. 2016; 44:5820&#x2013;36. 10.1093/nar/gkw499</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw499</ArticleId><ArticleId IdType="pmc">PMC4937342</ArticleId><ArticleId IdType="pubmed">27257061</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Bigio EH, Mishra M, Johnson N, Weintraub S, Mesulam M, Rademakers R, Chakraverty S, Cruchaga C, Morris JC, Goate AM, Cairns NJ. TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol. 2009; 118:633&#x2013;45. 10.1007/s00401-009-0571-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0571-7</ArticleId><ArticleId IdType="pmc">PMC2783457</ArticleId><ArticleId IdType="pubmed">19618195</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, and World Federation of Neurology Research Group on Motor Neuron Diseases. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1:293&#x2013;99. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai PC, Liu YC, Lin KP, Liu YT, Liao YC, Hsiao CT, Soong BW, Yip PK, Lee YC. Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2016; 40:191.e11&#x2013;16. 10.1016/j.neurobiolaging.2015.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.12.022</ArticleId><ArticleId IdType="pubmed">26804609</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper TA. Use of minigene systems to dissect alternative splicing elements. Methods. 2005; 37:331&#x2013;40. 10.1016/j.ymeth.2005.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2005.07.015</ArticleId><ArticleId IdType="pubmed">16314262</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>